Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.09
-0.07 (-6.03%)
At close: Oct 16, 2025, 3:57 PM
1.10
0.46%
After-hours: Oct 16, 2025, 07:32 PM EDT
-6.03% (1D)
| Bid | 1.08 |
| Market Cap | 26.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.1M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -1.92 |
| Forward PE | -1.91 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.19 |
| Volume | 81,841 |
| Avg. Volume (20D) | 556,600 |
| Open | 1.15 |
| Previous Close | 1.16 |
| Day's Range | 1.09 - 1.15 |
| 52-Week Range | 0.81 - 2.10 |
| Beta | 0.90 |
| Ex-Dividend Date | n/a |
About ENLV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENLV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENLV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
+20.37%
Elivex Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
11 months ago
-5.24%
Enlivex Therapeutics shares are trading higher after the company announced its board approved the purchase of up to $1 million in Bitcoin.
